DK1147778T3 - Stabil gelformulering til topisk behandling af hudtilstande - Google Patents

Stabil gelformulering til topisk behandling af hudtilstande

Info

Publication number
DK1147778T3
DK1147778T3 DK01202699T DK01202699T DK1147778T3 DK 1147778 T3 DK1147778 T3 DK 1147778T3 DK 01202699 T DK01202699 T DK 01202699T DK 01202699 T DK01202699 T DK 01202699T DK 1147778 T3 DK1147778 T3 DK 1147778T3
Authority
DK
Denmark
Prior art keywords
gel formulation
stable gel
skin conditions
gel
topical treatment
Prior art date
Application number
DK01202699T
Other languages
Danish (da)
English (en)
Inventor
Prakash M Charu
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK1147778T3 publication Critical patent/DK1147778T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
DK01202699T 1994-06-07 1995-06-07 Stabil gelformulering til topisk behandling af hudtilstande DK1147778T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25509494A 1994-06-07 1994-06-07
EP95923779A EP0764032B1 (fr) 1994-06-07 1995-06-07 Composition de gel stable pour le traitement topique de maladies de la peau

Publications (1)

Publication Number Publication Date
DK1147778T3 true DK1147778T3 (da) 2006-12-18

Family

ID=22966815

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01202699T DK1147778T3 (da) 1994-06-07 1995-06-07 Stabil gelformulering til topisk behandling af hudtilstande

Country Status (13)

Country Link
US (2) US5914334A (fr)
EP (2) EP1147778B1 (fr)
AT (2) ATE215836T1 (fr)
AU (1) AU693905B2 (fr)
CA (1) CA2191773C (fr)
DE (2) DE69526344T2 (fr)
DK (1) DK1147778T3 (fr)
ES (2) ES2269296T3 (fr)
IL (3) IL114049A (fr)
PT (1) PT1147778E (fr)
TW (1) TW379143B (fr)
WO (1) WO1995033489A1 (fr)
ZA (1) ZA954599B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA954599B (en) * 1994-06-07 1996-01-26 Allergan Inc Stable gel formulation for topical treatment of skin conditions
IT1288708B1 (it) * 1996-10-17 1998-09-23 Achille Sandoli Composizione farmaceutica comprendente trometamina per il trattamento per via topica dell'acne vulgaris.
AU730743B2 (en) * 1997-02-20 2001-03-15 Allergan, Inc. Tazarotene and corticosteroid treatment for psoriasis
ES2247699T3 (es) * 1997-06-11 2006-03-01 Allergan, Inc. Tratamiento de la psoriasis a base de tazaroteno y fototerapia.
WO1999049841A1 (fr) * 1998-03-30 1999-10-07 The Procter & Gamble Company Compositions pour soins de la peau
US20020160995A1 (en) * 1998-08-03 2002-10-31 Easterling W. Jerry Medication and method for remediating existing scars through transdermal, topical delivery of calcium channel blockers
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
CN101305994A (zh) * 2000-04-26 2008-11-19 沃特森药物公司 最小化与奥昔布宁疗法有关的副作用
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US7029694B2 (en) 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
FR2830449B1 (fr) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SI1511516T1 (sl) * 2002-05-28 2009-06-30 Nycomed Gmbh Topično uporaben farmacevtski pripravek
US20040018220A1 (en) * 2002-07-26 2004-01-29 Chiou Consulting, Inc. Aqueous compositions for facial cosmetics
RU2005122467A (ru) * 2002-12-17 2006-01-20 Галдерма Ресерч Энд Девелопмент, С.Н.С. (Fr) Способ химической стабилизации собилизированного ретиноида и водная композиция, полученная этим способом, содержащая по меньшей мере один ретиноид в виде соли
FR2848451B1 (fr) * 2002-12-17 2007-01-12 Galderma Res & Dev Procede de stabilisation chimique d'un retinoide solubilise et composition aqueuse obtenue selon le procede comprenant au moins un retinoide sous forme salifiee
NZ563270A (en) 2005-05-10 2010-11-26 Dermipsor Ltd Calcipotriol, polyethylene oxide topical compositions for the treatment of hyperproliferative epidermal diseases
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
US20070060620A1 (en) * 2005-09-09 2007-03-15 John Sefton Use of RAR retinoid agonists to increase sperm count and sperm mobility in males
WO2007041230A2 (fr) * 2005-09-30 2007-04-12 Omp, Inc. Compositions stables d'acide ascorbique
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
US9107844B2 (en) * 2006-02-03 2015-08-18 Stiefel Laboratories Inc. Topical skin treating compositions
PL2206494T3 (pl) 2006-03-31 2016-06-30 Stiefel Res Australia Pty Ltd Spienialny żel zawiesinowy
MXPA06008988A (es) * 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
WO2008106646A2 (fr) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Procédés et formulations pour une thérapie génique topique
US9107815B2 (en) 2008-02-22 2015-08-18 Allergan, Inc. Sustained release poloxamer containing pharmaceutical compositions
US20110117182A1 (en) * 2009-07-30 2011-05-19 Allergan, Inc. Combination of dapsone with other anti-acne agents
EP3251506A1 (fr) 2010-03-12 2017-12-06 Monsanto Technology LLC Compositions agrochimiques en forme de gel
WO2012046078A1 (fr) * 2010-10-08 2012-04-12 Helperby Therapeutics Limited Nouvelle composition
CA2929292C (fr) 2013-10-31 2021-11-02 Sun Pharmaceutical Industries Limited Composition pharmaceutique topique d'acitretine
US11311529B2 (en) * 2018-11-08 2022-04-26 Varsona Therapeutics, Inc. Topical formulations of 5-α-reductase inhibitors and uses thereof
US11311556B2 (en) 2020-05-13 2022-04-26 Varsona Therapeutics, Inc. Topical dutasteride emulsions for treating endocrine therapy-induced alopecia
KR20230039979A (ko) * 2021-09-15 2023-03-22 서울대학교산학협력단 아토피 피부염 예방 또는 치료용 겔 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3934028A (en) * 1974-04-22 1976-01-20 The Regents Of The University Of California Acne and psoriasis treatment with retinoic acid analogs
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US4810804A (en) * 1987-03-26 1989-03-07 Allergan, Inc. Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid-like activity
US5721275A (en) * 1989-06-07 1998-02-24 Bazzano; Gail S. Slow release vehicles for minimizing skin irritancy of topical compositions
AU670777B2 (en) * 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
ZA954599B (en) * 1994-06-07 1996-01-26 Allergan Inc Stable gel formulation for topical treatment of skin conditions
ES2247699T3 (es) * 1997-06-11 2006-03-01 Allergan, Inc. Tratamiento de la psoriasis a base de tazaroteno y fototerapia.
US6017938A (en) * 1998-07-28 2000-01-25 Bershad; Susan Short contact treatment for acne
US6114348A (en) * 1999-03-10 2000-09-05 Weber; Paul J. Method of treating warts using tazarotene

Also Published As

Publication number Publication date
DE69535184D1 (de) 2006-09-28
DE69526344D1 (de) 2002-05-16
EP0764032B1 (fr) 2002-04-10
IL122359A (en) 2001-08-26
IL114049A0 (en) 1995-10-31
PT1147778E (pt) 2006-12-29
CA2191773C (fr) 2004-08-10
DE69535184T2 (de) 2007-08-23
DE69526344T2 (de) 2002-11-07
AU693905B2 (en) 1998-07-09
ATE336263T1 (de) 2006-09-15
TW379143B (en) 2000-01-11
AU2821895A (en) 1996-01-04
ES2269296T3 (es) 2007-04-01
IL122358A (en) 2001-01-28
ATE215836T1 (de) 2002-04-15
WO1995033489A1 (fr) 1995-12-14
CA2191773A1 (fr) 1995-12-14
EP0764032A1 (fr) 1997-03-26
ZA954599B (en) 1996-01-26
EP1147778B1 (fr) 2006-08-16
US5914334A (en) 1999-06-22
US6258830B1 (en) 2001-07-10
ES2173958T3 (es) 2002-11-01
IL114049A (en) 2000-08-31
EP1147778A1 (fr) 2001-10-24

Similar Documents

Publication Publication Date Title
DK1147778T3 (da) Stabil gelformulering til topisk behandling af hudtilstande
IN1997DE00284A (fr)
ES2168414T3 (es) Formulaciones de retinoides en microesferas porosas de irritacion reducida y estabilidad aumentada.
PT1238660E (pt) Distribuicao sustentada de um agente activo utilizando um sistema implantavel
DE59510687D1 (de) Mittel gegen hyperreaktive und hypoaktive, defizitäre hautzustände sowie manifeste dermatiden
DK0892638T3 (da) Liposombaseret, topisk vitamin D-præparat
PT989846E (pt) Composicoes cosmeticas e farmaceuticas nao irritantes
FR2782269B1 (fr) Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation
ES2164434T3 (es) Tratamiento topico de psoriasis que utiliza anticuerpos neutralizantes de il-8.
DE69832171D1 (de) Derivate des 4-chinolols und land- und gartenbauwirtschaftliche bakterizide, die diese als aktiven bestandteil enthalten
DE69327808D1 (de) Methoxyiminoessigsäure-Derivate und Fungizide für Landwirtschaft und Gartenbau, die diese als aktive Bestandteile enthalten
FR2719768B1 (fr) Utilisation d'extraits de bactéries filamenteuses comme agents cosmétiques contre le vieillissement cutané.
ATE251443T1 (de) Antimikrobielle kosmetische präparate
DE59610213D1 (de) Gegen Akne und entzündete Comedonen wirksame Wirkstoffkombinationen
NO941097L (no) Hudregenererende kosmetisk preparat
SE9800730L (sv) Ny topikal formulering II
WO2004089083A3 (fr) Preparation antiparasitaire et appareil de distribution associe
BR9505116A (pt) Aplicaçao de ácido poliaspártico como agente de curtimento
ID17995A (id) Campuran stabil dari ramuan aktif yang tidak cocok untuk pelindung tanaman
ES2157551T3 (es) Pasta antihelmintica.
RU97107046A (ru) Мазь "аникол" для лечения ран, воспалительных и кожных заболеваний у животных
TW200503617A (en) Pest control formulation and dispenser
HUP9902703A2 (hu) Száraz peszticid készítmények állatokon előforduló ektoparaziták írtására